Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1393–1416 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Manipulation, Osteopathic
Interventions: OMT; Procedure
Lead sponsor: A.T. Still University of Health Sciences; Other
Eligibility: 20 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Kirksville, Missouri

Conditions: Meibomian Gland Dysfunction, Dry Eye Syndrome
Interventions: Sham Treatment, Pulsed Light Therapy; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Sexual Dysfunction
Interventions: Viveve System; Device
Lead sponsor: Michael Krychman, MD; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Neurogenic Urinary Bladder
Interventions: Alfuzosin, Placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 2 Years to 16 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Chronic Granulomatous Disease, Inflammatory Bowel Disease
Interventions: Neocate Splash; Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 8 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: General; Metabolic Disorder, Sexual Dysfunction, Hair Loss, Pathology
Interventions: Not listed
Lead sponsor: Roman Health Ventures Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Cognitive Impairment
Interventions: Transcutaneous vagal nerve stimulation, Sham stimulation; Device
Lead sponsor: University of Florida; Other
Eligibility: 60 Years to 89 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Gainesville, Florida

Conditions: Healthy, Neuromuscular Disease, Postpoliomyelitis Syndrome
Interventions: Electromyography; Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Opiate Dependence, Osteoporosis, Erectile Dysfunction, Hypogonadism
Interventions: Not listed
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Movement Disorders, Parkinson's Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment, Memory Disorders, Mild Dementia, Impaired Cognition, Mild Cognitive Disorder, Amnestic Disorder, Dementia and Amnestic Conditions, Poor Short-term Memory, Memory Impairment, Mild Neurocognitive Disorder
Interventions: Computerized brain fitness training, Yoga, Wellness Education, Support Group (patient and partner), Cognitive Rehabilitation; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Postoperative Delirium, Sleep, Anesthesia
Interventions: Dexmedetomidine, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years and older
Enrollment: 469 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Erectile Dysfunctions
Interventions: Low intensity shockwave therapy (LiSWT), Sham; Device
Lead sponsor: San Diego Sexual Medicine; Other
Eligibility: 21 Years to 80 Years · Male only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
Interventions: Liposomal Cyclosporine A, Standard of Care; Drug
Lead sponsor: Zambon SpA; Industry
Eligibility: 18 Years and older
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 21
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Peripheral Neuropathy, Autonomic Neuropathy
Interventions: Not listed
Lead sponsor: Weintraub, Michael I., MD, FACP, FAAN; Individual
Eligibility: 10 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Briarcliff Manor, New York

Conditions: Cognitive Decline, Social Isolation, Health Behaviors, Self Efficacy
Interventions: Wits Workout Program, Control Group that receives intervention after the study; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 50 Years and older
Enrollment: 285 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sexual Dysfunction, Physiological
Interventions: Estetrol, Placebo; Drug · Other
Lead sponsor: Estetra; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 24
States / cities: Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 20 more

Conditions: Left Ventricular Diastolic Dysfunction
Interventions: BNP (nesiritide), Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mild Cognitive Impairment
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: Duke University; Other
Eligibility: 55 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hematopoietic Stem Cell Transplantation, Cognitive Impairments, Sleep, Depression, Fatigue, Quality of Life
Interventions: Intervention systematic light exposure, Comparison systematic light exposure; Device
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aging, Cognitive Decline
Interventions: Physical Activity; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 55 Years to 79 Years
Enrollment: 145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Ventricular Dysfunction, Right, Hypoxia
Interventions: Hypoxia; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Food Insecurity
Interventions: Food Security Screening & Referral Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 5 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: La Jolla, California • San Diego, California

Conditions: Olfactory Disorder
Interventions: saline nasal irrigation; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Ultrasound Evaluation of OMT for Sacral Base Asymmetry

Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome

A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome

Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction

Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease

Blood Specimen Collection For Laboratory Assay Research

Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation

Electromyography to Diagnose Neuromuscular Disorders

Bone Density and Serum Testosterone in Male Methadone Maintained Patients

A Study of Movement Disorders Using the QMAT At-Home Testing Device

Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep

Sham-Controlled Prospective Study Characterizing Erectile Tissue Ultrasound Changes Resulting From Penile LiSWT

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study

Evaluation of the Wits Workout Wellness Program for Older Adults

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.

Using fMRI-guided TMS to Increase Central Executive Function in Older Adults (MCI_Sub)

The "Light for the Brain" Study

Yoga, Aerobic and Stretching Exercise Effects on Neurocognition

Impact of Hypoxia on Resting and Exertional Right Ventricular Performance

Implementing Food Referrals for Equity and Sustained Health

cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose